Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Jul 1:5:12044.
doi: 10.1038/srep12044.

Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials

Affiliations
Meta-Analysis

Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials

Tingting Qin et al. Sci Rep. .

Abstract

Numerous studies have investigated the effects of folic acid supplementation on colorectal cancer risk, but conflicting results were reported. We herein performed a meta-analysis based on relevant studies to reach a more definitive conclusion. The PubMed and Embase databases were searched for quality randomized controlled trials (RCTs) published before October 2014. Eight articles met the inclusion criteria and were subsequently analyzed. The results suggested that folic acid treatment was not associated with colorectal cancer risk in the total population (relative risk [RR] = 1.00, 95% confidence interval [CI] = 0.82-1.22, P = 0.974). Moreover, no statistical effect was identified in further subgroup analyses stratified by ethnicity, gender, body mass index (BMI) and potential confounding factors. No significant heterogeneity or publication bias was observed. In conclusion, our meta-analysis demonstrated that folic acid supplementation had no effect on colorectal cancer risk. However, this finding must be validated by further large studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1. A flow chart of the study identification and selection.
Figure 2
Figure 2. Forest plot of the association between colorectal cancer risk and folic acid supplementation.
The squares and horizontal lines correspond to the study-specific RR and 95% CI, respectively. The areas of the squares reflect the weight. The diamond represents the summary RR and 95% CI.
Figure 3
Figure 3. Begg’s funnel plot for the publication bias test.
Each point represents a separate study for the indicated association.

Similar articles

Cited by

  • Dietary Intervention for Preventing Colorectal Cancer: A Practical Guide for Physicians.
    Kim SH, Moon JY, Lim YJ. Kim SH, et al. J Cancer Prev. 2022 Sep 30;27(3):139-146. doi: 10.15430/JCP.2022.27.3.139. J Cancer Prev. 2022. PMID: 36258718 Free PMC article. Review.
  • Predictive value of GGN and CAG repeat polymorphisms of androgen receptors in testicular cancer: a meta-analysis.
    Jiang W, Zhang J, Zhou Q, Liu S, Ni M, Zhu P, Wu Q, Li W, Zhang M, Xia X. Jiang W, et al. Oncotarget. 2016 Mar 22;7(12):13754-64. doi: 10.18632/oncotarget.7337. Oncotarget. 2016. PMID: 26885616 Free PMC article.
  • Diet and microbiota in inflammatory bowel disease: The gut in disharmony.
    Rapozo DC, Bernardazzi C, de Souza HS. Rapozo DC, et al. World J Gastroenterol. 2017 Mar 28;23(12):2124-2140. doi: 10.3748/wjg.v23.i12.2124. World J Gastroenterol. 2017. PMID: 28405140 Free PMC article. Review.
  • Folate and Its Impact on Cancer Risk.
    Pieroth R, Paver S, Day S, Lammersfeld C. Pieroth R, et al. Curr Nutr Rep. 2018 Sep;7(3):70-84. doi: 10.1007/s13668-018-0237-y. Curr Nutr Rep. 2018. PMID: 30099693 Free PMC article. Review.
  • Genome-wide interaction analysis of folate for colorectal cancer risk.
    Bouras E, Kim AE, Lin Y, Morrison J, Du M, Albanes D, Barry EL, Baurley JW, Berndt SI, Bien SA, Bishop TD, Brenner H, Budiarto A, Burnett-Hartman A, Campbell PT, Carreras-Torres R, Casey G, Cenggoro TW, Chan AT, Chang-Claude J, Conti DV, Cotterchio M, Devall M, Diez-Obrero V, Dimou N, Drew DA, Figueiredo JC, Giles GG, Gruber SB, Gunter MJ, Harrison TA, Hidaka A, Hoffmeister M, Huyghe JR, Joshi AD, Kawaguchi ES, Keku TO, Kundaje A, Le Marchand L, Lewinger JP, Li L, Lynch BM, Mahesworo B, Männistö S, Moreno V, Murphy N, Newcomb PA, Obón-Santacana M, Ose J, Palmer JR, Papadimitriou N, Pardamean B, Pellatt AJ, Peoples AR, Platz EA, Potter JD, Qi L, Qu C, Rennert G, Ruiz-Narvaez E, Sakoda LC, Schmit SL, Shcherbina A, Stern MC, Su YR, Tangen CM, Thomas DC, Tian Y, Um CY, van Duijnhoven FJ, Van Guelpen B, Visvanathan K, Wang J, White E, Wolk A, Woods MO, Ulrich CM, Hsu L, Gauderman WJ, Peters U, Tsilidis KK. Bouras E, et al. Am J Clin Nutr. 2023 Nov;118(5):881-891. doi: 10.1016/j.ajcnut.2023.08.010. Epub 2023 Aug 26. Am J Clin Nutr. 2023. PMID: 37640106 Free PMC article.

References

    1. Sachdev H. P. & Gera T. Preventing childhood anemia in India: iron supplementation and beyond. European journal of clinical nutrition 67, 475–480, 10.1038/ejcn.2012.212 (2013). - DOI - PubMed
    1. Choi S. W. & Mason J. B. Folate and carcinogenesis: an integrated scheme. The Journal of nutrition 130, 129–132 (2000). - PubMed
    1. Metz J., Festenstein H. & Welch P. Effect of Folic Acid and Vitamin B12 Supplementation on Tests of Folate and Vitamin B12 Nutrition in Pregnancy. The American journal of clinical nutrition 16, 472–479 (1965). - PubMed
    1. Laurence K. M., James N., Miller M. H., Tennant G. B. & Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 282, 1509–1511 (1981). - PMC - PubMed
    1. Lange H. et al. Folate therapy and in-stent restenosis after coronary stenting. The New England journal of medicine 350, 2673–2681, 10.1056/NEJMoa032845 (2004). - DOI - PubMed

Publication types

MeSH terms